Refine by region/country

Bangladesh Strategy 2021: Return to high growth

IDLC Securities S. M. Galibur Rahman @ IDLC Securities
S. M. Galibur Rahman @
IDLC Securities
1 January 2021

SEARL enters exclusive license agreement with Beximco Pharma for Remdesivir

Yusra Beg 29 May 2020

Pakistan: Ferozsons in talks with Gilead to produce Covid-19 drug Remdesivir

Vahaj Ahmed 11 May 2020

2020 Saudi Equity Strategy

Irfan Ellam 20 January 2020

Vietnam 2020 investment strategy

Tu Vu 31 December 2019
Latest articles in Health Care

Bangladesh Strategy 2021: Return to high growth

Before the pandemic hit the country, Bangladesh's economy maintained a steady 6%+ growth rate during FY10-FY15 and 7.0%+ growth rate during FY16-FY18, and 8.15% in FY19. Bangladesh’s foreign exchange reserve reached USD 43bn landmark in December, 202...
IDLC Securities S. M. Galibur Rahman
S. M. Galibur Rahman @ IDLC Securities 1 January 2021
Bangladesh Strategy 2021: Return to high growth
Bangladesh Strategy 2021: Return to high growth

Egypt Pharma in 2021

Egypt is the MEA region’s largest producer and second-largest consumer of pharmaceuticals, growing by a CAGR (2013-2019) of 19%, surpassing the region’s CAGR of 8%. Market growth is predominantly driven by out of the pocket expenditure (61% of total...
Pharos Holding Mariam Wael
Mariam Wael @ Pharos Holding 28 December 2020
Egypt Pharma 2021: Not entirely defensive; Macro dynamics to support growth
Egypt Pharma 2021: Not entirely defensive; Macro dynamics to support growth

Chart of the WeekThe Crisis is Not Over, Keep Spending (Wisely)

The pandemic-induced economic crisis is set to leave deep scars. Human capital erosion from prolonged high unemployment and school closures, value destruction from bankruptcies, and constraints on future fiscal policy from elevated public debt top th...
International Monetary Fund
IMF Blog 2 November 2020
Chart of the WeekThe Crisis is Not Over, Keep Spending (Wisely)
Chart of the WeekThe Crisis is Not Over, Keep Spending (Wisely)

Unilever completes 82% acquisition of Glaxow BD, gaining ownership of HFD brands

Glaxow BD to become Unilever Consumer Care after the transfer of 9.88mn shares. Horlicks is the absolute market leader in the BDT4.1bn health food drinks (HFD) industry attaining 92% market share. On the other hand, GSK group will continue to market...
IDLC Securities Auneea Haque
Auneea Haque @ IDLC Securities 29 July 2020

Dexamethasone proves to be breakthrough drug for Covid-19

A UK government-funded trial has immediately approved Dexamethasone, an anti-inflammatory drug (corticosteroid), to treat all hospitalised Covid-19 patients requiring oxygen, including those on ventilators. SEARL has also recently entered licensing a...
Intermarket Securities Yusra Beg
Yusra Beg @ Intermarket Securities 17 June 2020

Safeguarding Africa’s Food Security in the Age of COVID-19

Food security in sub-Saharan Africa is under threat. As a result, lives are lost, malnutrition rises, health worsens, and school enrollment drops. The measures to contain and manage the COVID-19 pandemic, while critical to saving lives, risks exacerb...
International Monetary Fund
IMF Blog 4 June 2020
Safeguarding Africa’s Food Security in the Age of COVID-19
Safeguarding Africa’s Food Security in the Age of COVID-19